Keyphrases
Patients with Diabetes
100%
Skin Sympathetic Nerve Activity
100%
Cardiovascular Outcomes
100%
Autonomic Modulation
100%
Dipeptidyl peptidase-4 (DPP-4)
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Autonomic Nervous System
30%
Type 2 Diabetes Mellitus (T2DM)
20%
Type 2 Diabetic Patients
20%
Heart Rate
10%
In(III)
10%
Analytical Method
10%
Detrimental Effects
10%
Complex Patterns
10%
Favorable Outcome
10%
Most Complex
10%
Fire Duration
10%
Symbolic Entropy
10%
Adverse Events
10%
Second-line Treatment
10%
Change of Direction
10%
Autonomic Function
10%
Hemoglobin A1c (HbA1c)
10%
Firing Frequency
10%
Burst Analysis
10%
NeuECG
10%
A1c Levels
10%
Metformin Treatment
10%
Compelling Indications
10%
System Entropy
10%
Haemoglobin Target
10%
Medicine and Dentistry
Patient with Diabetes
100%
Nerve Conduction
100%
Sympathetic Nerve
100%
Cardiovascular System
100%
Dipeptidyl Peptidase-4 Inhibitor
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Autonomic Nervous System
40%
Maturity Onset Diabetes of the Young
20%
Patient with Type 2 Diabetes
20%
Electrocardiography
20%
Adverse Event
10%
Glycon
10%
Autonomic Function
10%
Neuroscience
Sympathetic Nerve
100%
Nerve Conduction
100%
Dipeptidyl Peptidase-4 Inhibitor
100%
Sodium Glucose Cotransporter 2
100%
Autonomic Nervous System
40%
Diabetes Mellitus
20%
Electrocardiography
20%
Metformin
10%